Clinical trial · Observational
The Association Between Watching Mukbang Videos and the Appetite of Children With Cancer
The Association of Mukbang Watching Behavior and the Appetite of Children With Cancer Hospitalized for Radiotherapy and Chemotherapy: An Intensive Longitudinal Study
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to record the "Mukbang" watching behavior and appetite of children with cancer during inpatient radiotherapy and chemotherapy through intensive longitudinal study, explore their correlation, and the impact on their nutritional status and quality of life, and formulate for clinical departments relevant interventions and management options provide a theoretical basis.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Mukbang | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Questionnaires set | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Questionnaires assessed children with cancer
- description
- Children with cancer who received at least one radiotherapy and chemotherapy during hospitalization
- interventionNames
- Other: Questionnaires set
Primary outcomes (2)
- measure
- Appetite
- timeFrame
- Appetite change over 5 days during chemoradiotherapy from baseline
- description
- The appetite will be assessed by Cancer Appetite and Symptom Questionnaire(CASQ) . The questionnaire consisted of 12 items, each item ranged from 0 to 4 points, and the total score of the questionnaire ranged from 0 to 48 points. The lower the total score, the worse the patient's appetite.
- measure
- Mukbang Watching Features
- timeFrame
- Mukbang Watching Features change over 5 days during chemoradiotherapy from baseline
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 3 Years
- Maximum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Aged 3-18； * Children who conform to the Notice on Printing and Distributing the Diagnosis and Treatment Specifications for 12 Diseases Related to Hematological Diseases and Malignancies in Children (2021 Edition) issued by the General Office of the National Health and Health Commission; * Experienced at least one complete cycle of chemotherapy and radiotherapy. Exclusion Criteria: * Children with severe cardiopulmonary disease, severe infection, severe organ damage, genetic metabolic disease, immunodeficiency disease or mental illness; * Children with eye and ear dysfunction at the same time, resulting in the inability to watch and listen to videos.
References
Publications (0)
Data not yet available